Drag a card by its title · ⚙ to size, swap or remove

The company

TriSalus Life Sciences, Inc.

TLSI · Nasdaq

Health CareMedical DevicesNot moving yet

TLSI stood above a rising 150-day average in 8 of the last 52 weekly readings, and has been out of that trend for the last 38 weeks. It is 14.9% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 38
Industry in uptrend: 29% -5 in 4 wk
Insider buys, 12 months: $7.2M
Insider sales, 12 months: $276K
Officials’ trades on record: 0
Institutions holding: 77 (-4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 8 of 52 weeks.

21 Apr – 20 Oct

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months10

Sale orders, 12 months18

Buyers · sellers6 · 5

Who	Did	Shares	Traded
Jennifer StevensChief Regulatory Officer	sold	316at $4.39	5 Oct 2026filed 7 Oct 2026
Richard MarshakChief Commercial Officer	sold	325at $4.39	5 Oct 2026filed 7 Oct 2026
Bryan F. CoxChief of Research	sold	296at $4.39	5 Oct 2026filed 7 Oct 2026
Gary B. GordonDirector	bought	10,000at $2.46	15 May 2026filed 18 May 2026
David PatienceChief Financial Officer	bought	7,100at $2.43	15 May 2026filed 18 May 2026
Mary T. SzelaCEO and President	bought	39,682at $2.59	15 May 2026filed 18 May 2026
Michael P. StanskyDirector	bought	410,000at $2.50	15 May 2026filed 18 May 2026
Michael P. StanskyDirector	bought	200,000at $2.50	15 May 2026filed 18 May 2026
Mats WahlstromDirector	bought	60,000at $2.53	15 May 2026filed 18 May 2026
Richard MarshakChief Commercial Officer	sold	543at $2.67	15 May 2026filed 19 May 2026
Mary T. SzelaCEO and President	sold	15,944at $3.85	17 Mar 2026filed 20 Mar 2026
Jennifer StevensChief Regulatory Officer	sold	774at $4.12	16 Mar 2026filed 20 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders77-4 on the quarter

New · exited15 · 18

Reported value$96.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
First Light Asset Management, LLCadded · filed 14 Aug 2026	6,552,491$29.8M	+1,485,664+29.3%
BlackRock, Inc.added · filed 7 Aug 2026	2,659,218$12.1M	+1,159,671+77.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,729,385$7.9M	+382,349+28.4%
Cerity Partners LLCadded · filed 14 Aug 2026	1,603,538$7.3M	+816,266+103.7%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	1,190,067$5.4M	+412,973+53.1%
Nantahala Capital Management, LLCreduced · filed 14 Aug 2026	1,000,000$4.5M	-1,070,827−51.7%
GILDER GAGNON HOWE & CO LLCreduced · filed 14 Aug 2026	850,081$3.9M	-38,434−4.3%
STATE STREET CORPadded · filed 7 Aug 2026	610,963$2.8M	+282,943+86.3%
WHITE PINE CAPITAL LLCadded · filed 5 Aug 2026	547,577$2.5M	+383,767+234.3%
KENNEDY CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 2026	476,261$2.2M	-8,981−1.9%